-
Portrait | 2023.06.12
Camille Berthelot, the Indiana Jones of endometriosis
Painful periods, menstruation, endometriosis, diagnostic odyssey – Camille Berthelot is not afraid to delve into topics that are sometimes seen as taboo but affect a large part of the world's population. She specializes in comparative genomics of species and leads her own group at the Institut Pasteur. She and her team are currently working to find a biological marker that could be used for early...
-
News | 2023.06.12
Parkinson's: connections in the brain identified as therapeutic targets
For the first time, scientists at the Institut Pasteur have identified connections between neurons and microglia, a type of immune cell in the brain. This discovery should help elucidate the role of inflammation in neurodegenerative diseases, potentially revealing new therapeutic targets.
-
Document de presse | 2023.06.08
The tiger mosquito can transmit the chikungunya virus in temperate conditions
The tiger mosquito Aedes albopictus, native to Southeast Asia, is one of two vectors for transmission of the chikungunya virus to humans. Scientists at the Institut Pasteur and Université Paris Cité have shown that this mosquito can acquire the ability to transmit the chikungunya virus as effectively at 20°C as at 28°C. The spread of the tiger mosquito in temperate climates could therefore result...
-
Document de presse | 2023.06.06
Monkeypox: characterization of post-infectious immune response
In 2022-2023, an outbreak of monkeypox, now known as mpox (caused by the monkeypox virus or MPXV) led to 87,000 human cases in 170 countries[1]. Most cases were reported outside the usual areas in which the virus circulates. Since the outbreak began, surveillance of the virus has been stepped up in Europe, with nearly 5,000 cases being reported in France[2]. Scientists and clinicians from the...
-
Document de presse | 2023.06.12
How the brain detects and regulates inflammation
How does the brain adapt our behavior in response to an infection or injury? A multidisciplinary team of scientists from the Institut Pasteur, CNRS and Inserm have revealed the existence of a circuit involved in sensing and also in the regulation of the anti-inflammatory response orchestrated by different brain regions. This circuit detects inflammation in the blood and organizes and regulates...
-
News | 2023.06.16
International: scientific partnerships and collaborations strengthened in 2022
The Institut Pasteur has been conducting its missions internationally since its creation in 1887. A policy of openness informs the Institut Pasteur’s strategic partnerships and scientific cooperation throughout the world, putting scientific excellence at the service of the health of populations. Also, as a cofounder of the Pasteur Network, the Institut Pasteur plays a key role in the co-...
-
News | 2023.06.12
Gut microbiota involved in depressive disorders
"A healthy mind... with a healthy microbiota." These words sum up a recent study demonstrating the close link between the composition of the gut microbiota and depressive disorders. In the same paper, the scientists also offered proof that direct communication between the gut microbiota and the brain requires the vagus nerve, paving the way for therapeutic solutions.
-
News | 2023.06.21
Malaria: parasite migration strategy revealed
Malaria is a disease transmitted by mosquitoes that are vectors of parasites in the genus Plasmodium. Scientists from the Institut Pasteur, in collaboration with specialized physicists in Brazil and Germany, have elucidated the search strategy used by parasites to reach the bloodstream.
-
News | 2023.06.28
From gene to patient, a decade of research to restore hearing
Scientists at the Hearing Institute, an Institut Pasteur Center, have established the full picture of therapeutic avenues for certain types of hearing impairments. They focused on so-called sensorineural deficiencies, caused by an anomaly in the inner ear or auditory nerve. Over the past 10 years, preclinical gene therapy studies have shown promising results. This research, aimed at restoring...
-
News | 2023.07.04
Extension of the Scope of the Exclusive Licence Granted by Institut Pasteur to Meletios Therapeutics for the Development of a New Class of Antivirals
The licensing agreement signed in 2022 between Institut Pasteur and Meletios Therapeutics, a French biotechnology company specialised in the research and development of next-generation antiviral treatments, concerns a cutting-edge technological platform for generating Defective Viral Genomes (DVGs) for the development of a new class of antivirals.
